|
| U.S. Brand
Names |
|
| Alomide®
Ophthalmic |

|
|
| Generic
Available |
|
|
No |

|
|
| Pharmacological Index |
|
|
Mast Cell Stabilizer |

|
|
| Use |
|
|
Treatment of vernal keratoconjunctivitis, vernal conjunctivitis, and vernal
keratitis |

|
|
| Pregnancy Risk
Factor |
|
|
B |

|
|
| Contraindications |
|
|
Hypersensitivity to any component of product |

|
|
| Warnings/Precautions |
|
|
Safety and efficacy in children <2 years of age have not been established;
not for injection; not for use in patients wearing soft contact lenses during
treatment |

|
|
| Adverse
Reactions |
|
|
>10%: Local: Transient burning, stinging, discomfort
1% to 10%:
Central nervous system: Headache
Ocular: Blurred vision, corneal erosion/ulcer, eye pain, corneal abrasion,
blepharitis
<1%: Dizziness, somnolence, rash, nausea, stomach discomfort, sneezing,
dry nose |

|
|
| Overdosage/Toxicology |
|
|
Symptoms include feeling of warmth of flushing, headache, dizziness, fatigue,
sweating, nausea, loose stools, and urinary frequency/urgency; consider emesis
in the event of accidental ingestion |

|
|
| Drug
Interactions |
|
|
No data reported |

|
|
| Mechanism of
Action |
|
|
Mast cell stabilizer that inhibits the in vivo type I immediate
hypersensitivity reaction to increase cutaneous vascular permeability associated
with IgE and antigen-mediated reactions |

|
|
| Pharmacodynamics/Kinetics |
|
|
Absorption: Topical: Very small and undetectable |

|
|
| Usual Dosage |
|
|
Children >2 years and Adults: Instill 1-2 drops in eye(s) 4 times/day for
up to 3 months |

|
|
| Mental Health: Effects
on Mental Status |
|
|
May cause drowsiness or dizziness |

|
|
| Mental Health:
Effects on Psychiatric
Treatment |
|
|
None reported |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
Do not wear soft contact lenses during treatment |

|
|
| Dosage Forms |
|
|
Solution, ophthalmic: 0.1% (10
mL) |

|
|
Copyright © 2007 Drugs Area
|